Optimal Duration of Oxaliplatin in Adjuvant XELOX for Gastric Cancer Patients (EXODOX)

NCT04787354 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

976

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Hallym University Medical Center